Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals

Background: The hepatitis C virus has a high mutation rate, which results in the emergence of resistance-associated substitutions (RASs). Despite direct-acting antivirals (DAAs) efforts to treat chronically infected HCV genotype 3 (GT3) patients, there are concerns about the emergence and persistenc...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Saima Mushtaq, Asraf Hussain Hashmi, Amjad Khan, Syed Muhammad Asad Raza Kazmi, Sobia Manzoor
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2022-04-01
Sarja:Frontiers in Pharmacology
Aiheet:
hepatitis C virus
genotype 3
direct-acting antiviral
relapse
resistance-associated substitutions
Linkit:https://www.frontiersin.org/articles/10.3389/fphar.2022.894460/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia